|
|
18 July 2016 |
Advanced Medical Solutions Group plc
(“AMS”, the “Company” or the “Group”)
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that it was notified on 14 July 2016 that Simon Coates, a Senior Manager and PDMR, had exercised 16,188 Ordinary Shares of 5p from the Deferred Share Bonus Plan, sold 5,768 shares from the total shares exercised (to satisfy income tax/National Insurance liabilities) and transferred 10,420 shares to Angela Coates (Simon Coates’s wife). In addition Simon Coates transferred 10,000 shares held in his name to a nominee account.
AMS was also notified that Pieter van Hoof, a Senior Manager and PDMR, had exercised 25,000 Ordinary Shares of 5p from the Long-Term Investment Plan and sold 11,809 shares from the total shares exercised (to satisfy income tax/National Insurance liabilities).
The two notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||||||||
|
a) |
Name: Simon Coates |
||||||||||||||||
2. |
Reason for the notification |
||||||||||||||||
|
a) |
Position/status: Senior Manager/PDMR |
||||||||||||||||
|
b) |
Initial notification/Amendment: Initial Notification |
||||||||||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||
|
a) |
Name: Advanced Medical Solutions Group plc |
||||||||||||||||
|
b) |
LEI: 213800HJP6OWOSZI1L74 |
||||||||||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
||||||||||||||||
|
b) |
Nature of the transaction: · Exercise of 16,188 Ordinary Shares of 5p from the Deferred Share Bonus Plan; · Sale of 5,768 shares from the total shares exercised (to satisfy income tax/National Insurance liabilities); · Transfer of 10,420 shares to Angela Coates (Simon Coates’s wife); and · Transfer of 10,000 shares to a nominee account. |
||||||||||||||||
|
c) |
Price(s) and volume(s): Exercise of Deferred Share Bonus Plan:
Sale of shares:
Transfer to Angela Coates:
Transfer to a nominee account:
|
||||||||||||||||
|
d) |
Aggregated information: (Relates to those shares sold only) Aggregated volume: 5,768 Aggregated price: £1.983547 |
||||||||||||||||
|
e) |
Date of the transaction: 14/07/2016 |
||||||||||||||||
|
f) |
Place of the transaction: London Stock Exchange, AIM Market (XLON) |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||
|
a) |
Name: Pieter van Hoof |
||||||||
2. |
Reason for the notification |
||||||||
|
a) |
Position/status: Senior Manager/PDMR |
||||||||
|
b) |
Initial notification/Amendment: Initial Notification |
||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||
|
a) |
Name: Advanced Medical Solutions Group plc |
||||||||
|
b) |
LEI: 213800HJP6OWOSZI1L74 |
||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
||||||||
|
b) |
Nature of the transaction: · Exercise of 25,000 Ordinary Shares of 5p from the Long-Term Investment Plan; and · Sale of 11,809 shares from the total shares exercised (to satisfy income tax/National Insurance liabilities). |
||||||||
|
c) |
Price(s) and volume(s): Exercise of options:
Sale of shares:
|
||||||||
|
d) |
Aggregated information: (relates to sale shares only) Aggregated volume: 11,809 Aggregated price: £1.983547 |
||||||||
|
e) |
Date of the transaction: 14/07/2016 |
||||||||
|
f) |
Place of the transaction: London Stock Exchange, AIM Market (XLON) |
– End –
For further information, please visit www.admedsol.com or contact:
|
Advanced Medical Solutions Group plc |
Tel: +44 (0) 1606 545508 |
|
Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director |
|
|
|
|
|
Consilium Strategic Communications |
Tel: +44 (0) 20 3709 5700 |
|
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys |
AMS@consilium-comms.com |
|
|
|
|
Investec Bank PLC (NOMAD & Broker) |
Tel: +44 (0) 20 7597 5970 |
|
Gary Clarence / Daniel Adams / Patrick Robb |
|
About Advanced Medical Solutions Group plc – see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.
AMS’s products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 510 employees. For more information please see www.admedsol.com.
This information is provided by RNS
END
DSHLLFEVDRITLIR